Polypropylene Market Growth and Analysis by 2020-2026 with Profiling Players

The global polypropylene market is anticipated to reach USD 120.11 billion by 2026 according to a new study published by Polaris Market Research. Polypropylene (PP), a thermoplastic is also referred to as addition polymer. It is named so, as it is made with the amalgamation of propylene monomers. The polymer was initially polymerized many years ago, precisely in 1951 by a team of Philips petroleum scientists. The team comprised Robert Banks, Paul Hogan, Natta, and Rehn. The actual commercialization of polypropylene began shortly after Professor Giulio Natta polymerized it.

By 1957, polypropylene gained high popularity throughout Europe and is presently the widely used plastics across the globe. It offers numerous benefits, one of which is its ability to get manufactured thorough ease and at a very large scale. It can be produced through various processes such as CNC, thermoforming, crimping, and injection molding, among others. It can be manufactured into living hinges, making it significantly light and thin without any bend or breaking. Thus, making it ideal for a variety of applications in industries such as automotive, consumer products, manufacturing, and industrial, among others.

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/global-polypropylene-market/request-for-sample

The list of key companies that are operating in the market include LyondellBasell, Japan Polypropylene Corporation, BASF AG, SABIC (Saudi Basic Industries Corporation), Braskem, China Petroleum & Chemical Corporation (Sinopec), Borealis AG, Total Refining and Chemicals Business, INEOS Olefins and Polymers Europe, ExxonMobil Chemical, Reliance Industries Limited, and PetroChina Co. Ltd., among others

Polypropylene can be easily copolymerized with other polymers such as polyethylene. Through copolymerization, significant changes are made to the properties of the material. Moreover, Polypropylene exhibits some significant properties such as high chemical resistance, elasticity, strength, fatigue resistance, transmissivity, and insulation. Thus, allowing large engineering applications, including toys, dishwasher, cups, safe plates, containers, and trays, among others.

Polypropylene has high application in both household and industrial applications. The unique properties and capabilities exhibited by the polymer facilitate varied application. In addition, it can be utilized as a plastic as well as fiber. Moreover, it can be manufactured via a number of processes. Thus, allowing the manufacturer to choose the most profitable procedure. From the past so many years, it is experiencing sustainable growth and is projected to dominate the demand in the plastic industry.

Have some specific queries about this report, our team of analyst will be glad to help! Click here : https://www.polarismarketresearch.com/industry-analysis/global-polypropylene-market/speak-to-analyst

Presently, there are only two types of polypropylene available in the market i.e. homopolymer and copolymers. Homopolymers are the widely used types and acquire a dominant position in the market. While, copolymers are largely utilized for applications that require the production of much clearer, and malleable products.

Currently, Asia Pacific holds a significant market share and is expected to retain its dominant position in the coming next eight years. This is primarily due to the rapidly growing demand for lightweight hybrid electric vehicles to encourage a decrease in carbon emissions.

Peptide Based Cancer Therapeutics Market Growth and Analysis by 2020-2027 with Profiling Players

The global peptide based cancer therapeutics market size is expected to reach USD 17.18 billion by 2027 according to a new study by Polaris Market ResearchPeptides are compounds that are created by natural or artificial biological linking of amino acid monomers. Peptides are being widely used in therapeutics to treat several ailments, including cancer owing to their precision based nature, targeting solid tumor cells in the body. Peptide based cancer therapeutics have shown effective results against cancer as opposed to conventional cancer treatments, without much side effects.

Peptide based therapies in the treatment of cancer are majorly classified as pure play peptide therapy, vaccines based on peptide, and peptide conjugate nanomaterials. These therapies possess several advantages over others such as easy administration, specificity in targeting tumor tissues, fewer side effects as compared to drugs, and low cost of peptides.

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/peptide-based-cancer-therapeutics-market/request-for-sample

Market participants such as AstraZeneca PLC, Abbott, Allergan plc, Teva Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical, Amgen, Inc., Johnson & Johnson, AbbVie Inc., and Valeant Pharmaceuticals Inc., are some of the key players operating in the concerned market. In January 2020, Sony Brook University (SBU) extended its funding on FABP5 inhibitors to 2025 by demonstrating novel approach to treat last stage prostate cancer. According to the researchers of the SBU specific fatty acid binding protein (FABP) may be help in stopping cancer.

In June 2017, AstraZeneca along with National Cancer Institute Eleven entered into cooperative research and development agreement with Eleven Biotherapeutics to develop Vicinium in combination with AstraZeneca’s immune checkpoint inhibitor, Imfinzi to treat non-muscle invasive bladder cancer.

The factors propelling the market growth are the increasing prevalence of cancer across the world, cancer screening programs in emerging countries, and the high specificity of peptide based cancer vaccines. In 2016, according to analysis by NCA (National Cancer Center), 1,010,200 cancer cases were recorded, with 576,100 male patients and 434,100 women cases. The mortality rate in 2016 recorded a high with more than 374,000 cancer deaths in the country, particularly deaths associated with the most common colorectal cancer followed by gastric, lung, prostrate and breast cancers.

Have some specific queries about this report, our team of analyst will be glad to help! Click here : https://www.polarismarketresearch.com/industry-analysis/peptide-based-cancer-therapeutics-market/speak-to-analyst

Percutaneous Coronary Intervention Devices Market Share, Industry Size, Opportunities, Analysis and Forecast To 2027

The global percutaneous coronary intervention (PCI) devices market size is expected to reach USD 11.4 billion by 2027 according to a new study by Polaris Market Research. Coronary artery disease (CAD) is causing most of deaths globally. The factors contributing to the disease include sedentary lifestyle, smoking, obesity, hereditary factors and alcohol usage. The mortality rate of CAD has been tremendously increasing grabbing the attention for researchers and clinicians globally, With the technological advancements in stent technologies, design of the guide wires, advent of next generation  coronary catheters (percutaneous transluminal coronary angioplasty (PTCA), percutaneous transluminal angioplasty (PTA) balloon catheters ), and the availability of coronary guide wires (steel based, nitinol based ) increased the treatment scope of the coronary heart diseases.

Polaris Market research has segmented the percutaneous coronary intervention (PCI) devices market report on the basis of product, end-use and region

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/percutaneous-coronary-intervention-pci-devices-market/request-for-sample

The emergence of dedicated catheterization labs in high income countries is also pivotal factor influencing the growth of the PCI devices market. The next generation Cath labs offers advanced services and performs interventional therapeutic procedures such as PCI, PTCA, epicardial ablations of ventricular tachycardia, aortic valve replacements and mitral valve repairs. Additionally, they also perform interventional cardiac electrophysiological procedures, pacemaker implantation and cardiac defibrillator implantation. The number of PCI procedures and other cardiac interventions is substantially increasing with the increase in the cardiovascular diseases globally.

To increase the performance of multi-specialty hospitals, many government and private hospitals are setting up catheterization labs for improved service offerings. This concept is gaining popularity for PCI procedures in Canada, the US, the UK, Germany, and other western countries. The factors favoring its growth include the conversion of physician’s office to alternate hospital providers, surgeons’ relationship with the manufacturers to eliminate the need of general practitioner officers (GPO), and the expansion of services provided by the hospitals.

Get Exclusive Discount on This Report : https://www.polarismarketresearch.com/industry-analysis/percutaneous-coronary-intervention-pci-devices-market/request-for-discount-pricing

Market participants such as Abbott, B. Braun, ASAHI INTECC Company Limited, Biosensors International Group, Ltd, Boston Scientific Corporation, C. R. Bard, BIOTRONIK, Comed BV, Cook, Meril Lifesciences, Cordis, Medtronic PLC, Merit Medical System, and Terumo Corporation are some of the key players operating in the percutaneous coronary intervention (PCI) devices market. Key vendors are investing huge amounts into their R&D and introducing new technologies and launching new products to stay competitive in this market. Several products were launched in the recent past with the latest next generation technology which caters the growing needs of the physician and the patients.